Montelukast as an episodic modifier for acute viral bronchiolitis: A randomized trial

Allergy and Asthma Proceedings

Volumn 31, Issue 2, 2010, Pages 147-153

  Zedan, Magdy ^a   Gamil, Nareman ^b   El Assmy, Mohamed ^a   Fayez, Engy ^b   Nasef, Nehad ^a   Fouda, Ashraf ^a   Settin, Ahmed ^a  

^a MANSOURA UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

Acute viral bronchiolitis; Clinical severity score; Episodic modifier; IFN gamma; IL 4; Length of hospital stay; Montelukast

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; MONTELUKAST; PLACEBO;

ACUTE VIRAL BONCHIOLITIS; ACUTE VIRAL BRONCHIOLITIS; ALLERGY; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FAMILY HISTORY; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT DURATION; TREATMENT OUTCOME; VIRAL BRONCHIOLITIS;

ACETATES; ACUTE DISEASE; ANTI-ASTHMATIC AGENTS; BRONCHIAL HYPERREACTIVITY; BRONCHIOLITIS, VIRAL; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFANT; INTERFERON-GAMMA; INTERLEUKIN-4; LENGTH OF STAY; MALE; QUINOLINES;

EID: 77950806749     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2010.31.3324     Document Type: Article

References (32)

1. Shay DK, Holman RC, Roosevelt GE, et al. Bronchiolitis-associated mortality and estimates of respiratory syncytial virusassociated deaths among US children, 1979-1997. J Infect Dis 183:16 -22, 2001.
2. Sigurs N. Epidemiologic and clinical evidence of a respiratory syncytial virus-reactive airway disease link. Am J Respir Crit Care Med 163:S2-S6, 2001. (Pubitemid 32336735)
3. Ogra LP. Respiratory syncytial virus: The virus, the disease and the immune response. Paediatr Respir Rev 5:S119-126, 2004.
4. Jartti T, Makela M, Vanto T, et al. The link between bronchiolitis and asthma. Infect Dis Clin North Am 19:667-689, 2005.
5. Tripp RA, Moore D, Barskey A IV, et al. Peripheral blood mononuclear cells from infants hospitalized because of respiratory syncytial virus infection express T helper-1 and T helper-2 cytokines and CC chemokine messenger RNA. J Infect Dis 185:1388-1394, 2002. (Pubitemid 34507959)
6. Behera AK, Kumar M, Matsuse H, et al. Respiratory syncytial virus induces the expression of 5-lipoxygenase and endothelin-1 in bronchial epithelial cells. Biochem Biophys Res Commun 251:704-709, 1998. (Pubitemid 28512774)
7. Wedde-Beer K, Hu C, Rodriguez MM, et al. Leukotrienes mediate neurogenic inflammation in lungs of young rats infected with respiratory syncytial virus. Am J Physiol 282:1143-1150, 2002. (Pubitemid 34654633)
8. Volovitz B, Welliver RC, De Castro G, et al. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: Role in obstructive airway disease. Pediatr Res 24:504-507, 1988.
9. Van Schaik SM, Tristram DA, Nagpal IS, et al. Increased production of IFN-gamma and cysteinyl leukotrienes in virusinduced wheezing. J Allergy Clin Immunol 103:630-636, 1999.
10. Salvi SS, Krishna MT, Sampson AP, et al. The antiinflammatory effects of leukotriene-modifying drugs and their use in asthma. Chest 119:1533-1546, 2001.
11. Gadomski AM, and Bhasale AL. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev 3:CD001266, 2006.
12. Patel H, Platt R, and Lozano JM. WITHDRAWN: Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev 1:CD004878, 2008.
13. Zhang L, Mendoza-Sassi RA, Wainwright C, et al. Nebulized hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev 4:CD006458, 2008. (Pubitemid 351805842)
14. Fitzgerald A, and Mellis C. Leukotriene receptor antagonists in virus-induced wheezing. Treat Respir Med 5:407-417, 2006.
15. Ciprandi G, Frati F, Marcucci F, et al. Nasal cytokine modulation by montelukast in allergic children: A pilot study. Allerg Immunol (Paris) 35:295-299, 2003. (Pubitemid 37377053)
16. Bisgaard H. Study Group on Montelukast and Respiratory Syncytial Virus. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am J Respir Crit Care Med 167:379-383, 2003.
17. Wang EE, Milner RA, Navas L, et al. Observer agreement for respiratory signs and oximetry in infants hospitalized with lower respiratory infections. Am Rev Respir Dis 145:106-109, 1992.
18. Dallal G. Randomization. Available online at www.randomization. com; last modified July 16, 2008; last accessed January 2009.
19. Sznajer Y, Westcott JY, Wenzel SE, et al. Airway eicosanoids in acute severe respiratory syncytial virus bronchiolitis. J Pediatr 145:115-118, 2004. (Pubitemid 38962462)
20. Takahashi Y, Ichikawa M, Nawate M, et al. Clinical evaluation of urinary leukotriene e4 levels in children with respiratory syncytial virus infection. Arerugi 52:1132-1137, 2003. (Pubitemid 38146080)
21. Piedimonte G, Renzetti G, Auais A, et al. Leukotriene synthesis during respiratory syncytial virus bronchiolitis: Influence of age and atopy. Pediatr Pulmonol 40:285-291, 2005. (Pubitemid 41437604)
22. Oommen A, and Grigg J. Urinary leukotriene E4 in preschool children with acute clinical viral wheeze. Eur Respir J 21:149-154, 2003. (Pubitemid 36150315)
23. Amirav I, Luder A, Kruger N, et al. A double-blind, placebocontrolled, randomized trial of montelukast for acute bronchiolitis. Pediatrics 122:e1249-e1255, 2008.
24. Gern JE. Viral respiratory infection and the link to asthma. Pediatr Infect Dis J 27:S97-S103, 2008.
25. Parry DE, Busse WW, Sukow KA, et al. Rhinovirus-induced peripheral blood mononuclear cell responses and outcome of experimental infection in allergic subjects. J Allergy Clin Immunol 105:692-698, 2000.
26. Gern JE, Vrtis R, Grindle KA, et al. Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med 162:2226-2231, 2000. (Pubitemid 32051692)
27. Becker Y. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy - A review. Virus Genes 33:235-252, 2006. (Pubitemid 44401431)
28. Ji JZ, Chen ZG, Chen YF, et al. Effect of leukotriene receptor antagonist on the levels of Th1 and Th2 cytokines in sera of infants with respiratory syncytial virus pneumonia. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 21:132-134, 2007.
29. Gentile DA, and Skoner DP. Effect of respiratory syncytial virus infection during early infancy on the ontogeny of cytokine immune responses. Allergy Asthma Proc 23:399-405, 2002.
30. Thivierge M, Stankova J, and Rola-Pleszczynski M. IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages. J Immunol 167:2855-2860, 2001. (Pubitemid 32768919)
31. Chibana K, Ishii Y, Asakura T, et al. Up-regulation of cysteinyl leukotriene 1 receptor by IL-13 enables human lung fibroblasts to respond to leukotriene C4 and produce eotaxin. J Immunol 170:4290-4295, 2003. (Pubitemid 36428197)
32. Mellor E, Maekawa A, Austen KF, et al. Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells. Proc Natl Acad Sci USA 98:7964-7969, 2001. (Pubitemid 32642670)